Johner Institute New Zealand Ltd.’s Post

𝗧𝗵𝗲 𝗨.𝗦. 𝗙𝗼𝗼𝗱 𝗮𝗻𝗱 𝗗𝗿𝘂𝗴 𝗔𝗱𝗺𝗶𝗻𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 (𝗙𝗗𝗔) 𝗵𝗮𝘀 𝗿𝗲𝗹𝗲𝗮𝘀𝗲𝗱 𝗮 𝗱𝗿𝗮𝗳𝘁 𝗴𝘂𝗶𝗱𝗮𝗻𝗰𝗲 𝘁𝗶𝘁𝗹𝗲𝗱 "𝗦𝗲𝗹𝗲𝗰𝘁 𝗨𝗽𝗱𝗮𝘁𝗲𝘀 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗣𝗿𝗲𝗺𝗮𝗿𝗸𝗲𝘁 𝗖𝘆𝗯𝗲𝗿𝘀𝗲𝗰𝘂𝗿𝗶𝘁𝘆 𝗚𝘂𝗶𝗱𝗮𝗻𝗰𝗲: 𝗦𝗲𝗰𝘁𝗶𝗼𝗻 𝟱𝟮𝟰𝗕 𝗼𝗳 𝘁𝗵𝗲 𝗙𝗗&𝗖 𝗔𝗰𝘁." This document suggests revised recommendations for industry on cybersecurity considerations for medical devices and the documentation required in premarket submissions. It aims to introduce specific updates to the existing "Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions" guidance, notably adding a new section to address considerations for cyber devices. This section outlines the cybersecurity information generally necessary to fulfil obligations under section 524B of the FD&C Act. Until this draft is finalised, the current Premarket Cybersecurity Guidance continues to reflect the FDA's stance on the subject. 📌 𝐒𝐮𝐛𝐦𝐢𝐭 𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐬 𝐨𝐧 𝐭𝐡𝐞 𝐃𝐫𝐚𝐟𝐭 𝐆𝐮𝐢𝐝𝐚𝐧𝐜𝐞  To have your comments considered by the FDA before finalisation, submit them under docket number FDA-2021-D-1158 at www.regulations.gov by 13 May 2024. 📅 𝐔𝐩𝐜𝐨𝐦𝐢𝐧𝐠 𝐖𝐞𝐛𝐢𝐧𝐚𝐫  The FDA will conduct a webinar on 30 April 2024, to provide more information about the draft guidance. https://lnkd.in/d3Gv8QHA 👉 Do you have questions about cybersecurity? Johner Institute New Zealand is here to help! Contact us at: info@johner-institute.nz #FDA #Cybersecurity #HealthcareTechnology #MedicalDevices #PublicHealth

To view or add a comment, sign in

Explore topics